1) Cancer-related anemia
癌性贫血
1.
Objective: To investingate the possibility of increased incidence of thrombosis in cancer-related anemia mice treated with erythropoietin, and to provide experimental evidence for clinical safe usage.
目的:探讨基因重组人促红细胞生成素治疗癌性贫血小鼠时是否增加荷瘤小鼠血栓形成的危险性,为临床上的安全使用提供实验依据。
2) Xuexu tumor anemia
血虚型癌性贫血
1.
Objective: To observe the clinical efficacy of Jianpi Yishen Buqi Yangxue Tang,which is under the guidance of Jianpi Yishen Buqi Yangxue Method,in treating Xuexu tumor anemia patients with advanced-stage NSCLC.
目的:观察用健脾益肾补气养血法指导的健脾益肾生血汤治疗晚期NSCLC患者血虚型癌性贫血的临床疗效。
3) antianemia property
抗贫血性
4) renal anemia
肾性贫血
1.
Effects of naked plasmid expressing human erythropoietin for the treatment of renal anemia;
表达人红细胞生成素裸质粒治疗肾性贫血的实验研究
2.
Effect of L-carnitine and rhEPO on renal anemia in hemodialysis patients;
左旋卡尼汀联用促红细胞生成素治疗血液透析患者肾性贫血的疗效观察
3.
Effect of high flux dialysis on maintenance of hemodialysis patients with renal anemia and its possible mechanism;
高通量透析可改善维持性血液透析患者肾性贫血
5) chronic anemia
慢性贫血
1.
Results 32 cases were caused by Zagaris disease, 50 cases were caused by candidiasis infection, and 57 cases were caused by chronic anemia.
结果32例由口干引起,50例由念珠菌感染引起,57例由慢性贫血引起。
6) Hepatic anemia
肝性贫血
补充资料：传染性溶血性贫血
传染性溶血性贫血
即"感染性贫血"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条